Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Black Hills Corp. Announces Quarterly Dividend
-
First Guaranty Bank Bridgeport, WV Branch Officially Opens
-
First Guaranty Bank Bridgeport, WV Branch Officially Opens
-
Saia Expands Network in New Jersey and Utah
-
ROSEN, A LEADING LAW FIRM, Encourages JBS S.A. Investors to Inquire About Securities Class Action Investigation – JBSAY
-
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation – WALD, WALDW
-
Trinity University (San Antonio) Chemistry Professor Named as Fellow to American Association for Advancement of Science (AAAS)
-
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-
Western Investment Company Gives Notice of Trade Resumption on April 23, 2024 and Provides Update on the Shares it has Secured in Fortress Insurance
-
Universal Transit Launches Equity Fundraising Campaign on Republic Platform
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages World Acceptance Corporation Investors to Inquire About Securities Class Action Investigation – WRLD
-
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Mattr Announces Closing of Its Credit Facility
-
Arbor Biotechnologies to Present Data Supporting Therapeutic Programs in PH1 and ALS, and the Discovery of a Novel Type V Nuclease at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual
-
Ribera y Rueda, Spain’s Most Prestigious Wine Regions, Celebrate Over 2,000 Years of Winemaking Heritage
-
Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice
-
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
-
Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; D
-
Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; Dilut
-
Bombardier Completes Partial Redemption of US$200,000,000 of its 7.875% Senior Notes due 2027
-
SmartFinancial Announces Results for the First Quarter 2024
-
Parker to Announce Fiscal 2024 Third Quarter Earnings on May 2; Conference Call and Webcast Scheduled for 11 a.m. Eastern Time
-
Scorpius Holdings Announces Receipt of Filing Delinquency Notification
-
Finning to report Q1 2024 results on May 6 and hold investor call on May 7, 2024
-
NCLA Amicus Brief Tells D.C. Circuit It Must Avoid Remanding Regulations Without Vacating Them
-
Lithium Argentina to Release First Quarter 2024 Results on May 13, 2024
-
First Bank Announces First Quarter 2024 Net Income of $12.5 Million
-
EMGA secures US$ 15M financing for Banco Improsa in Costa Rica
-
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27t
-
Ring Therapeutics Announces Presentations at the 27th Annual American Society of Gene and Cell Therapy
-
Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting
-
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
-
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
-
iLearningEngines Reports Fourth Quarter and Full Year 2023 Results
-
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
-
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
-
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
-
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
-
GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
-
Kriya Announces Six Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
-
Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV Program, EBT-107, at the Upcoming ASGCT 2024 Annual Meeting
-
CNL FINANCIAL GROUP ANNOUNCES NEW NATIONAL SALES DIRECTOR
-
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
-
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
-
CrossAmerica Partners LP Maintains Quarterly Distribution
-
CrossAmerica Partners LP Maintains Quarterly Distribution
-
Vertex Provides Preliminary Financial Results for First Quarter 2024 and Announces First Quarter Earnings Call Date
-
Vertex, Inc. Announces Proposed Private Offering of $250 Million of Convertible Senior Notes
-
NBT Bancorp Inc. Announces First Quarter 2024 Results
